Search results for Ensituximab
Ensituximab, Abbexa, abx831198
Ensituximab is a monoclonal antibody biosimilar expressed in CHO cells, targeting MUC5AC, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Ensituximab has been used in trials studying the treatment of Pancreatic Cancer, Adult, Metastatic Colorectal Cancer, and Metastatic Pancreatic Cancer.
Host
Human, Mouse
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Ensituximab Biosimilar - Research Grade, ichor.bio, ICH5527
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Research Grade Ensituximab (HX246016), abinScience, HX246016
Host
Chimeric
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Ensituximab Vedotin Biosimilar - Research Grade, ichor.bio, ICH5527V
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Please provide the required information below so that we can quickly source your products.